Randomized Phase III Trial Exploring the Use of LongActing Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics